1 / 8

CLOPIDOGREL AND PPI’S

CLOPIDOGREL AND PPI’S. KAVITHA KANAKANTI. Aim. To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors. Reason of Audit.

clinton
Download Presentation

CLOPIDOGREL AND PPI’S

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CLOPIDOGREL AND PPI’S KAVITHA KANAKANTI

  2. Aim • To confirm the number of patients who were on Clopidogrel are taking Proton Pump Inhibitors.

  3. Reason of Audit • Numerous studies examined the clinical outcomes of patients taking clopidogrel and suggested that a significant interaction occurs between clopidogrel and PPIs, making clopidogrel less effective • One possible explanation for this observation is that some PPIs prevent the conversion of clopidogrel into its biologically active form in the body

  4. Reason of Audit • It reduces the effectiveness of clopidogrel and increasing the risk of heart attack or other conditions involving harmful clotting (e.g. strokes).

  5. The EU Committee for Medicinal Products for Human Use (CHMP) has stated that the concomitant use of a proton pump inhibitor (PPI) with clopidogrel is not recommended unless considered essential.

  6. Method • The patients were chosen from the computer records who have been requesting repeat prescriptions of clopidogrel for the last 6 months • Medical records from this group of patients were checked manually if they were on PPI’s.

  7. Results • 62 patients were identified who were on Clopidogrel • Among these patients, 28 were also on PPI’s. • The medical records for these patients were highlighted with the information about interaction between clopidogrel and PPI’s.

  8. Action Plan • The interaction between clopidogrel and PPI’S to be discussed with the patient in the next appointment and PPI’s changed to appropriate drug depending on patients needs. • A re-audit need to be done to see if the action has been implemented in 6 months time.

More Related